Insights
- Home
- /
- Insights
Our Insights

We Acquires Leading Preclinical Services Provider T3 Labs2
We are excited to announce the acquisition of T3 Labs, a premier preclinical services provider known for its excellence in translational research and state-of-the-art laboratory capabilities. This strategic move enhances our ability to support early-stage medical device and pharmaceutical development, further expanding our expertise in preclinical testing and innovation. By integrating T3 Labs’ advanced facilities and experienced team into our operations, we’re committed to delivering even greater value to our clients and accelerating the journey from concept to clinic.


We Acquires Leading Preclinical Services Provider T3 Labs1
We are excited to announce the acquisition of T3 Labs, a premier preclinical services provider known for its excellence in translational research and state-of-the-art laboratory capabilities. This strategic move enhances our ability to support early-stage medical device and pharmaceutical development, further expanding our expertise in preclinical testing and innovation. By integrating T3 Labs’ advanced facilities and experienced team into our operations, we’re committed to delivering even greater value to our clients and accelerating the journey from concept to clinic.


We Acquire Leading Preclinical Services Provider T3 Labs
We are proud to announce the acquisition of T3 Labs, a renowned preclinical services provider with a strong reputation for advancing medical research and innovation. This acquisition reflects our commitment to strengthening our capabilities in preclinical testing, accelerating the development of medical devices and therapies, and supporting our clients from early research through to clinical success. T3 Labs’ exceptional team, state-of-the-art facilities, and robust scientific expertise will be a valuable addition to our organization as we continue to expand our reach and impact in the healthcare and life sciences industries.


Strengthening Our Preclinical Services Through T3 Labs Acquisition
Building on our commitment to innovation and excellence, we have expanded our preclinical service capabilities through the acquisition of T3 Labs. This partnership enhances our portfolio by incorporating advanced research technologies and specialized expertise, enabling us to offer comprehensive solutions to our clients. With T3 Labs joining our team, we are better positioned to accelerate development timelines, improve research quality, and support the evolving needs of the medical and pharmaceutical industries.



Join Us in Transforming Healthcare
We invite you to be a part of the healthcare revolution. Collaborate with us to drive innovation, improve patient outcomes, and shape the future of healthcare. Together, let’s make a difference in the lives of millions.